Extranodal classical Hodgkin lymphoma involving the spinal cord: case report and review of the literature

References

• LauwMIS, LucasCHG, OhgamiRS, WenKW. Primary central nervous system lymphomas: a diagnostic overview of key histomorphologic, immunophenotypic, and genetics features. Diagnostics10(12), 1076 (2020).
   Web of Science ®Google Scholar
• OstromQT, GittlemanH, XuJet al.CBTRUS Statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro. Oncol.18, v1–v75 (2016).
   PubMed Web of Science ®Google Scholar
• GerstnerER, AbreyLE, SchiffDet al.CNS Hodgkin lymphoma. Blood112(5), 1658–1661 (2008).
   PubMed Web of Science ®Google Scholar
• FermeC, EghbaliH, MeerwaldtJHet al.Chemotherapy plus involved-field radiation in early-stage Hodgkin’s disease. N. Engl. J. Med.357(19), 1916–1927 (2007).
   PubMed Web of Science ®Google Scholar
• GatcombeH, LawsonJ, PhuphanichS, CrockerI. Treatment related myelitis in Hodgkin’s lymphoma following stem cell transplant, chemotherapy and radiation: a case report and review of the literature. J. Neurooncol.79(3), 293–298 (2006).
   PubMed Web of Science ®Google Scholar
• LydingJM, TsengA, NewamanA, CollinsS, SheaW. Intramedullary spinal cord metastasis in Hodgkin’s lymphoma. Cancer60(8), 1741–1744 (1987).
   PubMedGoogle Scholar
• HigginsSA, PeschelRE. Hodgkin’s disease with spinal cord compression. A case report and a review of the literature. Cancer75(1), 94–98 (1995).
   PubMed Web of Science ®Google Scholar
• JardinF, StamatoullasA, FruchartC, D’AnjouJ, ClementJF, TillyH. Atteinte de la moelle épinière et envahissement meningé lors d’une maladie de Hodgkin. A propos d’un cas et revue de la littérature. Rev. Med. Intern.20(3), 267–271 (1999).
   PubMedGoogle Scholar
• RiffaudL, AdnM, BrassierG, MorandiX. Acute cauda equina compression revealing Hodgkin’s disease: a case report. Spine28(14), 270–272 (2003).
   Web of Science ®Google Scholar
• HeranNS, YongRL, HeranMS, YipS, FairholmD. Primary intradural extra-arachnoid hodgkin lymphoma of the cervical spine. Case report. J. Neurosurg. Spine5(1), 61–64 (2006).
   PubMed Web of Science ®Google Scholar
• KilaniB, AmmariL, TiouiriH, KanounF, BenRomdhane K, BenChaabane T. Transverse myelitis revealing Hodgkin disease. Presse Med.35(4 Pt 1), 615–617 (2006).
   PubMed Web of Science ®Google Scholar
• Al-KhayatH, Al-BakerO, GroofAet al.Cervical radiculopathy secondary to Hodgkin’s lymphoma. Sur. Neurol.67(5), 540–543 (2007).
   PubMedGoogle Scholar
• SamadianM, VahidiS, KhormaeeF, AshrafH. Isolated primary spinal epidural Hodgkin’s disease in a child. Pediatr. Neurol.40(6), 480–482 (2009).
   PubMed Web of Science ®Google Scholar
• ChotaiN, DuttaR. Primary intradural Hodgkin’s lymphoma in lumbosacral spine: a rare location. Clin. Neuroradiol.20(4), 247–249 (2010).
   PubMed Web of Science ®Google Scholar
• YamanO, OzdemirN, SevinIE, OzerFD, UnluogluS. Primary spinal epidural Hodgkin’s lymphoma. J. Surg. Case Rep.2013(10), rjt090 (2013).
   PubMedGoogle Scholar
• MartinezDL, GujratiM, GeoffroyF, TsungAJ. Isolated CNS Hodgkin’s lymphoma: implications for tissue diagnosis. CNS Oncol.3(6), 383–387 (2014).
   PubMedGoogle Scholar
• WilliamsonTJ, WangM, ClarkJ, WilliamsJ, DrndaA. Primary intradural Hodgkin lymphoma of the cornus medullaris and cauda equina: case report. CNS Oncol.9(3), 52 (2020).
   Google Scholar
• BloxhamN, CrossJ, GarnettMet al.Hodgkin lymphoma presenting with spinal cord compression: challenges for diagnosis and initial management. Pediatr. Dev. Pathol.24, 10935266211033269 (2021).
   Google Scholar
• FerreriAJM. Therapy of primary CNS lymphoma: role of intensity, radiation, and novel agents. Hematology Am. Soc. Hematol. Educ. Program.2017(1), 565–577 (2017).
   PubMed Web of Science ®Google Scholar
• GrommesC, RunbensteinJL, DeAngelisLM, FerreriAJM, BatchelorTT. Comprehensive approach to diagnosis and treatment of newly diagnosed primary CNS lymphoma. Neuro-Oncol.21(3), 296–305 (2019).
   PubMed Web of Science ®Google Scholar
• KeaneyJ, CampbellM. The dynamic blood-brain barrier. FEBS J.282(21), 4067–4079 (2015).
   PubMed Web of Science ®Google Scholar
• SprowlsSA, ArsiwalaTA, BumgarnerJRet al.Improving CNS delivery to brain metastases by blood-tumor barrier disruption. Trends Cancer5(8), 495–505 (2019).
   PubMed Web of Science ®Google Scholar
• CirilloM, CraigAFM, BorchmannS, KurtzD. Liquid biopsy in lymphoma: molecular methods and clinical applications. Cancer Treat. Rev.91, 102106 (2020).
   PubMed Web of Science ®Google Scholar
• YanW, XuT, ZhuH, YuJ. Clinical applications of cerebrospinal fluid circulating tumor DNA as a liquid biopsy for central nervous system tumors. Onco. Targets Ther.13, 719–731 (2020).
   PubMed Web of Science ®Google Scholar
• MomotowJ, BorchmannS, EichenauerDA, EngertA, SasseS. Hodgkin lymphoma review on pathogeneis, diagnosis, current and future treatment approaches for adult patients. J. Clin. Med.10(5), 1125 (2021).
   PubMed Web of Science ®Google Scholar
• BorchmannP, GoergenH, KobeCet al.PET-guided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised Phase III trial by the German Hodgkin Study Group. Lancet390(10114), 2790–2802 (2017).
   PubMed Web of Science ®Google Scholar
• CasasnovasRO, BouabdallahR, BricePet al.Positron emission tomography-driven strategy in advanced Hodgkin lymphoma: prolonged follow-up of the ALH 2011 Phase III lymphoma Study Association Study. J. Clin. Oncol.40(10), 1091–1101 (2022).
   PubMed Web of Science ®Google Scholar
• EichenauerDA, PlütschowA, KreisslSet al.Incorporation of Brentuximab vedotin into first-line treatment of advanced classical Hodgkin’s lymphoma: final analysis of a Phase II randomised trial by the German Hodgkin Study Group. Lancet Oncol.18(12), 1680–1687 (2017).
   PubMed Web of Science ®Google Scholar
• GobbiPG, FedericoM. What has happened to VBM (vinblastine, bleomycin and methotrexate) chemotherapy for early-stage Hodgkin lymphoma?Crit. Rev. Oncol. Hematol.82(1), 18–24 (2012).
   PubMed Web of Science ®Google Scholar
• JahnkeK, DoolittleND, MuldoonLL, NeuweltEA. Implications of the blood–brain barrier in primary central nervous system lymphoma. Neurosurg. Focus21(5), E11 (2006).
   PubMedGoogle Scholar
• GallaminiA, RossiA, PattiCet al.Consolidation radiotherapy could be safely omitted in advanced Hodgkin lymphoma with large nodal mass in complete metabolic response after ABVD: final analysis of the randomized GITIL/FIL HD0607 trial. J. Clin. Oncol.38(33), 3905–3913 (2020).
   PubMed Web of Science ®Google Scholar
• SpechtL, YahalomJ, IllidgeTet al.Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int. J. Radiat. Oncol. Biol. Phys.89(4), 854–862 (2014).
   PubMed Web of Science ®Google Scholar
• ShahN, MohammadAS, SaralkarPet al.Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. Phamacol. Res.132, 47–68 (2018).
   PubMed Web of Science ®Google Scholar
• ChangJH, ShinJH, YamadaYJet al.Stereotactic body radiotherapy for spinal metastases: what are the risks and how do we minimize them?Spine41(Suppl. 20), S238–S245 (2016).
   PubMed Web of Science ®Google Scholar